2022 World Conference on Lung Cancer (ePosters)-EP06.01-014. Lung Resections After COVID: Short-term Outcomes

Pdf Summary

A retrospective study conducted at Tata Memorial Hospital in Mumbai, India investigated the outcomes of lung resections in patients who had previously tested positive for COVID-19. The study included a total of 186 patients who underwent surgery between April 2020 and December 2021, with 26 (14.1%) of them testing positive for COVID-19 preoperatively.<br /><br />The study found that lung resections can be safely performed in post-COVID patients. However, it also identified the potential for immune flare-ups, characterized by microabscess formation and placental transmogrification, which can lead to poor outcomes. Three patients in the study experienced a severe post-operative immune flare-up, similar to acute respiratory distress syndrome (ARDS), with one patient responding to steroids and the other two unfortunately passing away.<br /><br />The outcomes of this study suggest that while lung resections can be conducted safely in patients who have recovered from COVID-19, there is a need for careful monitoring and consideration of potential immune flare-ups. This highlights the importance of identifying and managing postoperative complications in patients with a history of COVID-19.<br /><br />Overall, this study provides valuable insights into the short-term outcomes of lung resections in post-COVID patients and emphasizes the importance of further research and understanding in this area. These findings may help inform clinical decision-making and improve patient outcomes in the future.

Asset Subtitle

Srinivas Kodaganur Gopinath

Meta Tag

Speaker Srinivas Kodaganur Gopinath

Topic Management of Lung Cancer in the Era of COVID-33

Keywords

retrospective study

Tata Memorial Hospital

Mumbai

India

lung resections

COVID-19

outcomes

immune flare-ups

postoperative complications

patient outcomes